SAFE-HEaRt: A pilot study assessing the cardiac safety of HER2 targeted therapy in patients with HER2 positive breast cancer and reduced left ventricular function.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Filipa Lynce, Ana Barac, Xue Geng, Chau T. Dang, Anthony Francis Yu, Karen L. Smith, Christopher Gallagher, Paula Raffin Pohlmann, Raquel Nunes, Pia Maarit Herbolsheimer, Robert D. Warren, M. Barbara Srichai, Mark Hofmeyer, Andrecia Cunningham, Patricia Timothee, Federico M Asch, Ayesha N Shajahan-Haq, Ming Tony Tan, Claudine Isaacs, Sandra M. Swain
Institutions: Georgetown University Medical Center, Georgetown Lombardi Comprehensive Cancer Center, MedStar Heart & Vascular Institute, Memorial Sloan Kettering Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, MedStar Washington Hospital Center, MedStar Health Research Institute
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2806824901